225 related articles for article (PubMed ID: 31448100)
1. Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy.
Tadiotto Cicogna G; Messina F; Nalotto L; Szekely S; Alaibac M
F1000Res; 2019; 8():336. PubMed ID: 31448100
[TBL] [Abstract][Full Text] [Related]
2. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.
Sfikakis PP; Iliopoulos A; Elezoglou A; Kittas C; Stratigos A
Arthritis Rheum; 2005 Aug; 52(8):2513-8. PubMed ID: 16052599
[TBL] [Abstract][Full Text] [Related]
5. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
Cirone KD; Lovegrove FE
SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
[TBL] [Abstract][Full Text] [Related]
6. [Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].
García C; Arellano J; Vera V; Corredoira Y
Medwave; 2020 Sep; 20(8):e8021. PubMed ID: 32956338
[TBL] [Abstract][Full Text] [Related]
7. Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.
Iijima S; Okazaki Y; Watanabe S; Maruyama Y
J Dermatol; 2014 Nov; 41(11):1006-8. PubMed ID: 25346303
[TBL] [Abstract][Full Text] [Related]
8. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
[TBL] [Abstract][Full Text] [Related]
9. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.
Crowley EL; Maliyar K; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
SAGE Open Med Case Rep; 2019; 7():2050313X19829620. PubMed ID: 30800311
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report.
Nguyen A; D'Aguanno K; Ridha Z; Tsoukas A; Netchiporouk E
SAGE Open Med Case Rep; 2023; 11():2050313X231180775. PubMed ID: 37359284
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
Miller AC; Holland TE; Cohen DJ
J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
[TBL] [Abstract][Full Text] [Related]
12. Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.
Shi L; Zeng L; Huang X; Wang B; Zhang Y; Zhang G
Clin Cosmet Investig Dermatol; 2023; 16():951-957. PubMed ID: 37051587
[TBL] [Abstract][Full Text] [Related]
13. Case of acrodermatitis continua accompanied by psoriatic arthritis.
Jo SJ; Park JY; Yoon HS; Youn JI
J Dermatol; 2006 Nov; 33(11):787-91. PubMed ID: 17073995
[TBL] [Abstract][Full Text] [Related]
14. Acrodermatitis continua of Hallopeau response to optimized biological therapy.
Adas A; Dadban A; Arnault JP; Chaby G; Lok C
Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865417
[TBL] [Abstract][Full Text] [Related]
15. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis.
Abbas O; Itani S; Ghosn S; Kibbi AG; Fidawi G; Farooq M; Shimomura Y; Kurban M
Dermatology; 2013; 226(1):28-31. PubMed ID: 23428889
[TBL] [Abstract][Full Text] [Related]
16. Two cases of acrodermatitis continua of Hallopeau associated with generalized arthritis.
Okuno H; Ogura K; Okuyama R; Itoi E
Acta Dermatovenerol Croat; 2013; 21(4):265-7. PubMed ID: 24476617
[TBL] [Abstract][Full Text] [Related]
17. Pustular Psoriasis and Associated Musculoskeletal Disorders.
Duffin KC; Bachelez H; Mease PJ; Rosen C; Garg A; Zudak E; Elkayam O; Merola JF; Chau J; Kishimoto M; Furer V; Helliwell PS
J Rheumatol Suppl; 2021 Jun; 97():34-38. PubMed ID: 34074664
[TBL] [Abstract][Full Text] [Related]
18. Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast.
Lanna C; Cesaroni GM; Mazzilli S; Lozzi F; Palumbo V; Diluvio L; Bianchi L; Campione E
Dermatol Ther; 2019 Jul; 32(4):e12946. PubMed ID: 31025500
[TBL] [Abstract][Full Text] [Related]
19. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
Kazinski K; Joyce KM; Hodson D
J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
[TBL] [Abstract][Full Text] [Related]
20. Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
Khosravi-Hafshejani T; Zhou Y; Dutz JP
J Rheumatol; 2019 Apr; 46(4):437-438. PubMed ID: 30936225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
